Your browser doesn't support javascript.
loading
Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination.
Collins, Erin; Galipeau, Yannick; Arnold, Corey; Bosveld, Cameron; Heiskanen, Aliisa; Keeshan, Alexa; Nakka, Kiran; Shir-Mohammadi, Khatereh; St-Denis-Bissonnette, Frederic; Tamblyn, Laura; Vranjkovic, Agatha; Wood, Leah C; Booth, Ronald; Buchan, C Arianne; Crawley, Angela M; Little, Julian; McGuinty, Michaeline; Saginur, Raphael; Langlois, Marc-André; Cooper, Curtis L.
Afiliación
  • Collins E; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada ecoll098@uottawa.ca.
  • Galipeau Y; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Arnold C; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Bosveld C; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Heiskanen A; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Keeshan A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Nakka K; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Shir-Mohammadi K; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • St-Denis-Bissonnette F; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Tamblyn L; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Vranjkovic A; Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Wood LC; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Booth R; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Buchan CA; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Crawley AM; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Little J; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • McGuinty M; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Saginur R; Immunology Section, Eastern Ontario Regional Laboratory Association (EORLA), Ottawa, Ontario, Canada.
  • Langlois MA; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Cooper CL; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
BMJ Open ; 12(9): e062187, 2022 09 08.
Article en En | MEDLINE | ID: mdl-36691221
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido